Abstract
The ketogenic diet (KD) is still viewed as virtually last-line therapy in childhood epilepsies, and specifically as unsafe and difficult to initiate and maintain in neonates and infants. Information is presented to show that the KD is safe and efficacious in this population, and should be carefully studied to determine its real usefulness as first-line or early therapy (one or fewer anticonvulsants) in the catastrophic epilepsies of infancy.
Original language | English (US) |
---|---|
Pages (from-to) | 30-32 |
Number of pages | 3 |
Journal | Epilepsia |
Volume | 49 |
Issue number | SUPPL. 8 |
DOIs | |
State | Published - Nov 2008 |
Externally published | Yes |
Keywords
- Epilepsy
- Infants
- Ketogenic diet
- Neonates
ASJC Scopus subject areas
- Neurology
- Clinical Neurology